ClinicalTrials.gg
Drug class

GABA Agonists clinical trials

A class of medicines: the studies that test any of its 3 members, each study once. Members are as MeSH files each medicine’s actions, and as the NCI Thesaurus classes newer ones.

studies test it
23
open now
0
in phase 3
14
first study started
2003

Medicines in this class

Studies that test each. A study of two counts under both, and once above.

Adipiplon
1

Studies by the year they started

23 studies that test it; most in 2004 (6)

Studies that test GABA Agonists, by start year
YearStudies
20032
20046
20053
20061
20082
20091
20161
20171
20181
20192
20211
20221
20241

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
6
Phase 3
14
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 20 · Other 3

H. Lundbeck A/S (10) · Ovid Therapeutics Inc. (3) · Bellus Health Inc. - a GSK company (3) · Healx AI (2) · Craig Erickson (1) · Vanderbilt University Medical Center (1) · Neurogen Corporation (1) · Aristotle University Of Thessaloniki (1)

Studies

Open first, then newest update. How each study uses a medicine is read from its arms, and is right about nine times in ten. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing one of them · 23

See all 23 studies that test one of the gaba agonists →

Codes

What other systems call GABA Agonists · ClinicalTrials.gg INT008649

  • MeSH (NLM) D018755GABA AgonistsOne source ClinicalTrials.gov

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.